Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs, announced today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the Jefferies 2017 Global Healthcare Conference.

An audio webcast of the presentation will be available on the Investors section of the company website, www.veronapharma.com.  A replay of the webcast will be made available for 90 days following the presentation.

Event: Jefferies Healthcare ConferenceDate: June 8, 2017Time: 11:30 AM EDT Location: New York, NY

For further information, please contact:

Verona Pharma plc           Tel: +44 (0)20 3283 4200
Jan-Anders Karlsson, Chief Executive Officer           info@veronapharma.com 
             
N+1 Singer (Nominated Adviser and UK Broker)           Tel: +44 (0)20 7496 3000
Aubrey Powell / James White            
             
FTI Consulting (UK Media and Investor enquiries)           Tel: +44 (0)20 3727 1000
Simon Conway / Stephanie Cuthbert / Natalie Garland-Collins           veronapharma@fticonsulting.com 
             
ICR, Inc. (US Media and Investor enquiries)            
James Heins           Tel: +1 203-682-8251James.Heins@icrinc.com
             
Stephanie Carrington           Tel. +1 646-277-1282Stephanie.Carrington@icrinc.com 
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Verona Pharma Charts.
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Verona Pharma Charts.